
STIs (Structured Treatment Interruptions) involve going off anti-HIV therapy for periods of time in a structured and strategic fashion, typically guided by increased lab and health monitoring. In all, more than two dozen studies of STIs of varying types have been conducted since 1998. It is important to note that interpreting the results of STI research can be challenging. Some of the assumptions about HIV disease that led researchers to investigate treatment interruptions in the first place have yet to be proven conclusively. At least some of the research on STIs, however, has been promising and other research has made clear those areas where interrupting therapy is neither safe nor effective.
Anti-HIV Agents, Humans, HIV Infections, Drug Administration Schedule, CD4 Lymphocyte Count
Anti-HIV Agents, Humans, HIV Infections, Drug Administration Schedule, CD4 Lymphocyte Count
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
